Protea Biosciences Group Valuation

Based on Macroaxis valuation methodology, the company cannot be evaluated at this time. Protea Biosciences recent Real Value cannot be determined due to lack of data. The prevailing price of Protea Biosciences is $0.0. Our model determines the value of Protea Biosciences from analyzing the company fundamentals such as Current Valuation of 11.29 M, return on equity of -31.9, and Shares Owned By Insiders of 49.85 % as well as examining its technical indicators and probability of bankruptcy. In general, most investors support taking in undervalued entities and trading overvalued entities since, at some point, asset prices and their ongoing real values will merge together.

Protea Biosciences Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Protea Biosciences's current stock value. Our valuation model uses many indicators to compare Protea Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Protea Biosciences competition to find correlations between indicators driving Protea Biosciences's intrinsic value. More Info.
Protea Biosciences Group is rated below average in price to earning category among related companies. It is rated below average in price to sales category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Protea Biosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Protea Biosciences' OTC BB Equity. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Protea Biosciences' earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Protea Biosciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Protea Biosciences and how it compares across the competition.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Note that the Protea Biosciences information on this page should be used as a complementary analysis to other Protea Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Consideration for investing in Protea OTC BB Equity

If you are still planning to invest in Protea Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Protea Biosciences' history and understand the potential risks before investing.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum